IGF-1 LR3
IGF-1 LR3: A modified insulin-like growth factor studied in growth signalling.
What is it?
A modified insulin-like growth factor studied in growth signalling.
How it is studied
The LR3 designation identifies an IGF-1 analogue. It must not be treated as identical to native IGF-1.
What the evidence says
The linked source concerns a defined compound or studied formulation. It does not verify this supplier vial.
What remains uncertain
Exact identity and formulation must be confirmed against supplier documents. No personal dosing or treatment recommendation is provided.
Sources & scope
For in-vitro laboratory research only. Not for human or veterinary use.